For: | Bangolo AI, Trivedi C, Jani I, Pender S, Khalid H, Alqinai B, Intisar A, Randhawa K, Moore J, De Deugd N, Faisal S, Suresh SB, Gopani P, Nagesh VK, Proverbs-Singh T, Weissman S. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights. World J Gastroenterol 2023; 29(25): 3984-3998 [PMID: PMC10354587 DOI: 10.3748/wjg.v29.i25.3984] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i25/3984.htm |
Number | Citing Articles |
1 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023. World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
Abstract(611) |
Core Tip(587) |
Full Article(HTML)(3406)
|
Full Article with Cover (PDF)-1825K(200)
|
Full Article (Word)-130K(37)
|
Audio-14227K(21)
|
Peer-Review Report-222K(71)
|
Answering Reviewers-194K(60)
|
Full Article (PDF)-407K(184)
|
Full Article (XML)-119K(78)
|
Times Cited (0)
|
Total Visits (10304)
|
Open
|
2 |
Yu-Meng Qin, Jie Sha. Progress in understanding of relationship between intestinal microecology and pancreatic cancer. World Chinese Journal of Digestology 2023; 31(24): 1001 doi: 10.11569/wcjd.v31.i24.1001
|
3 |
Adekunle Rowaiye, Gordon C. Ibeanu, Doofan Bur, Sandra Nnadi, Odinaka E. Mgbeke, Ugonna Morikwe. Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapies. The Microbe 2024; 4: 100096 doi: 10.1016/j.microb.2024.100096
|
4 |
Donatella Delle Cave. Emerging Therapeutic Options in Pancreatic Cancer Management. International Journal of Molecular Sciences 2024; 25(3): 1929 doi: 10.3390/ijms25031929
|
5 |
Sara Fanijavadi, Lars Henrik Jensen. Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes. International Journal of Molecular Sciences 2025; 26(2): 730 doi: 10.3390/ijms26020730
|